Receptor-Interacting Serine-threonine Kinase 2 (RIPK2) (Middle Region) Peptide
Quick Overview for Receptor-Interacting Serine-threonine Kinase 2 (RIPK2) (Middle Region) Peptide (ABIN8110154)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- RIPK2 Peptide - middle region
-
Sequence
- SLNIPVNHGP QEESCGSSQL HENSGSPETS RSLPAPQDND FLSRKAQDCY
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti- RIPK2 Antibody (ARP80889_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- RIPK2 (Receptor-Interacting Serine-threonine Kinase 2 (RIPK2))
-
Background
-
Background Information: This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein contains a C-terminal caspase activation and recruitment domain (CARD), and is a component of signaling complexes in both the innate and adaptive immune pathways. It is a potent activator of NF-kappaB and inducer of apoptosis in response to various stimuli.
Alternative Symbols: CCK, RICK, RIP2, CARD3, GIG30, CARDIAK
-
Molecular Weight
- 59 kDa
-
Gene ID
- 8767
-
NCBI Accession
- NP_003812
-
UniProt
- O43353
Target
-
